Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20‐Year Follow‐Up

Background Hyperuricemia is associated with poor cardiovascular outcomes, although it is uncertain whether this relationship is causal in nature. This study aimed to: (1) assess the heritability of serum uric acid (SUA) levels, (2) conduct a genome‐wide association study on SUA levels, and (3) investigate the association between certain single‐nucleotide polymorphisms and target organ damage. Methods and Results The STANISLAS (Suivi Temporaire Annuel Non‐Invasif de la Santé des Lorrains Assurés Sociaux) study cohort is a single‐center longitudinal cohort recruited between 1993 and 1995 (visit 1), with a last visit (visit 4 [V4]) performed ≈20 years apart. Serum lipid profile, SUA, urinary albumin/creatinine ratio, estimated glomerular filtration rate, 24‐hour ambulatory blood pressure monitoring, transthoracic echocardiography, pulse wave velocity, and genotyping for each participant were assessed at V4. A total of 1573 participants were included at V4, among whom 1417 had available SUA data at visit 1. Genome‐wide association study results highlighted multiple single‐nucleotide polymorphisms on the SLC2A9 gene linked to SUA levels. Carriers of the most associated mutated SLC2A9 allele (rs16890979) had significantly lower SUA levels. Although SUA level at V4 was highly associated with diabetes, prediabetes, higher body mass index, CRP (C‐reactive protein) levels, estimated glomerular filtration rate variation (visit 1–V4), carotid intima‐media thickness, and pulse wave velocity, rs16890979 was only associated with higher carotid intima‐media thickness. Conclusions Our findings demonstrate that rs16890979, a genetic determinant of SUA levels located on the SLC2A9 gene, is associated with carotid intima‐media thickness despite significant associations between SUA levels and several clinical outcomes, thereby lending support to the hypothesis of a link between SUA and cardiovascular disease.

[1]  F. Zannad,et al.  Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up. , 2020, American journal of hypertension.

[2]  Edith Le Floch,et al.  Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort. , 2019, European journal of preventive cardiology.

[3]  P. McKeigue,et al.  Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study , 2019, PLoS medicine.

[4]  J. Dawson,et al.  Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials , 2019, Journal of the American Heart Association.

[5]  Y. Kamatani,et al.  Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout , 2019, Annals of the rheumatic diseases.

[6]  G. Bedoya,et al.  Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease. , 2019, International journal of cardiology.

[7]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[8]  G. Ndrepepa.  Uric acid and cardiovascular disease. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[9]  M. Lanaspa,et al.  Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver , 2018, Scientific Reports.

[10]  M. Lanaspa,et al.  Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects , 2018, Nutrients.

[11]  S. Frančula-Zaninović,et al.  Management of Measurable Variable Cardiovascular Disease' Risk 
Factors , 2018, Current cardiology reviews.

[12]  M. Dorobanțu,et al.  Serum uric acid and arterial hypertension—Data from Sephar III survey , 2018, PloS one.

[13]  F. Zannad,et al.  Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France. , 2018, International journal of epidemiology.

[14]  Youquan Gu,et al.  Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[15]  I. Mortada.  Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association , 2017, Current Hypertension Reports.

[16]  A. Roda,et al.  Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review , 2017, Nutrients.

[17]  M. Lanaspa,et al.  Dietary and commercialized fructose: Sweet or sour? , 2017, International Urology and Nephrology.

[18]  M. Lanaspa,et al.  Serum Uric Acid and Risk for Acute Kidney Injury Following Contrast , 2017, Angiology.

[19]  A. Jurjus,et al.  Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association , 2016, Current Hypertension Reports.

[20]  Lawrence A Leiter,et al.  Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies , 2016, BMJ Open.

[21]  Y. Bao,et al.  Association between serum uric acid related genetic loci and diabetic kidney disease in the Chinese type 2 diabetes patients. , 2016, Journal of diabetes and its complications.

[22]  X. Yang,et al.  Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis , 2016, Rheumatology International.

[23]  M. Lanaspa,et al.  Uric acid in metabolic syndrome: From an innocent bystander to a central player. , 2016, European journal of internal medicine.

[24]  Tom R. Gaunt,et al.  Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis , 2016, The lancet. Diabetes & endocrinology.

[25]  J. Danesh,et al.  Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. , 2016, Journal of the American College of Cardiology.

[26]  C. Zoccali,et al.  A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[27]  S. Sharma,et al.  Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia , 2015, Journal of Investigative Medicine.

[28]  B. Thorens,et al.  No development of hypertension in the hyperuricemic liver-Glut9 knockout mouse. , 2015, Kidney international.

[29]  I. Hisatome,et al.  Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[30]  T. Merriman.  An update on the genetic architecture of hyperuricemia and gout , 2015, Arthritis Research & Therapy.

[31]  S. Cole,et al.  Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study. , 2015, The American journal of clinical nutrition.

[32]  J. Wang,et al.  Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies , 2014, PloS one.

[33]  J. Banegas,et al.  Tubular Urate Transporter Gene Polymorphisms Differentiate Patients with Gout Who Have Normal and Decreased Urinary Uric Acid Excretion , 2014, The Journal of Rheumatology.

[34]  C. Zoccali,et al.  Association of a polymorphism in a gene encoding a urate transporter with CKD progression. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[35]  K. Kaneko,et al.  Total purine and purine base content of common foodstuffs for facilitating nutritional therapy for gout and hyperuricemia. , 2014, Biological & pharmaceutical bulletin.

[36]  M. Kanbay,et al.  Effects of Allopurinol on Endothelial Dysfunction: A Meta-Analysis , 2014, American Journal of Nephrology.

[37]  B. Afşar,et al.  An Update on Coronary Artery Disease and Chronic Kidney Disease , 2014, International journal of nephrology.

[38]  Benjamin R. Szwejkowski,et al.  159 ALLOPURINOL REDUCES LEFT VENTRICULAR MASS IN PATIENTS WITH TYPE 2 DIABETES AND LEFT VENTRICULAR HYPERTROPHY , 2013, Heart.

[39]  L. Almasy,et al.  Genome-wide association analysis confirms and extends the association of SLC2A9 with serum uric acid levels to Mexican Americans , 2013, Front. Genet..

[40]  Tom M Palmer,et al.  Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts , 2013, BMJ.

[41]  A. Shuldiner,et al.  Genotype-based changes in serum uric acid affect blood pressure. , 2012, Kidney international.

[42]  F. Turgut,et al.  Serum Uric Acid Level and Endothelial Dysfunction in Patients with Nondiabetic Chronic Kidney Disease , 2011, American Journal of Nephrology.

[43]  Hyon K. Choi,et al.  Hyperuricemia and incident hypertension: A systematic review and meta‐analysis , 2011, Arthritis care & research.

[44]  M. Kanbay,et al.  Uric Acid and Hypertension: Cause or Effect? , 2010, Current rheumatology reports.

[45]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[46]  I. Hisatome,et al.  Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans* , 2008, Journal of Biological Chemistry.

[47]  P. Elliott,et al.  SLC2A9 Is a High-Capacity Urate Transporter in Humans , 2008, PLoS medicine.

[48]  Braxton D Mitchell,et al.  Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. , 2008, Arthritis and rheumatism.

[49]  Mario Falchi,et al.  Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia , 2022 .

[50]  S. Bandinelli,et al.  The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts , 2007, PLoS genetics.

[51]  Sudha Seshadri,et al.  The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports , 2007, BMC Medical Genetics.

[52]  L. Truong,et al.  A role for uric acid in the progression of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[53]  J. Hughes,et al.  Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism , 2001, Hypertension.

[54]  G. Pagano,et al.  Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes , 2001, European journal of clinical investigation.

[55]  M. Shichiri,et al.  Diabetic hypouricemia as an indicator of clinical nephropathy. , 1990, American journal of nephrology.